Determination of nifurtimox in dog plasma by stable-isotope dilution LC-MS/MS.

Bioanalysis

Drug Metabolism & Pharmacokinetics, Pharmaceutical Research Center, Bayer HealthCare AG, Aprather Weg 18A, D-42096 Wuppertal, Germany.

Published: November 2015

Background: Nifurtimox is a 5-nitrofuran derived antiprotozoal drug used to treat diseases caused by trypanosomes including Chagas' disease and sleeping sickness (African trypanosomiasis). Available methods for the determination of nifurtimox in plasma are tedious and of low sensitivity. For the first time, an isotope dilution HPLC/MS/MS method for the sensitive quantitation of nifurtimox down to 10.0 μg/l in plasma is described.

Results: Protein precipitation was used for sample preparation. Samples were analyzed on a standard triple quadrupole tandem mass spectrometer. The validated concentration range covers 10.0 μg/l (LLOQ) to 5000 μg/l. Interassay accuracy and precision (%CV) ranged from 98.4 to 101%, and 2.61 to 10.1%, respectively.

Conclusion: The method consists of very simple sample preparation and provides unmatched sensitivity, high reproducibility and robustness enabling analysis of large sample numbers. Method performance met current guidelines on bioanalytical method validation.

Download full-text PDF

Source
http://dx.doi.org/10.4155/bio.15.185DOI Listing

Publication Analysis

Top Keywords

determination nifurtimox
8
100 μg/l
8
sample preparation
8
nifurtimox dog
4
dog plasma
4
plasma stable-isotope
4
stable-isotope dilution
4
dilution lc-ms/ms
4
lc-ms/ms background
4
background nifurtimox
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!